Phase II study of peginterferon alfa-2b (PegIntron)/Sylatron for pediatric patients with progressive or recurrent craniopharyngioma following radiotherapy: A Pediatric Brain Tumor Consortium study (PBTC-039) Meeting Abstract


Authors: Goldman, S.; Pollack, I.; Kun, L.; Billups, C.; Broniscer, A.; Robinson, G.; Dhall, G.; Robison, N.; Panigrahy, A.; Poussaint, T. Y.; Adesina, A.; Onar-Thomas, A.; Jakacki, R.; Dunkel, I.; Fouladi, M.
Abstract Title: Phase II study of peginterferon alfa-2b (PegIntron)/Sylatron for pediatric patients with progressive or recurrent craniopharyngioma following radiotherapy: A Pediatric Brain Tumor Consortium study (PBTC-039)
Meeting Title: 18th International Symposium on Pediatric Neuro-Oncology (ISPNO 2018)
Journal Title: Neuro-Oncology
Volume: 20
Issue: Suppl. 2
Meeting Dates: 2018 Jun 29-Jul 3
Meeting Location: Denver, CO
ISSN: 1522-8517
Publisher: Oxford University Press  
Date Published: 2018-06-22
Start Page: i40
End Page: i41
Language: English
ACCESSION: WOS:000438339000059
PROVIDER: wos
DOI: 10.1093/neuonc/noy059
PMCID: PMC6012612
Notes: Meeting Abstract: CRAN-21 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ira J Dunkel
    371 Dunkel